Document Detail


Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
MedLine Citation:
PMID:  2399887     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We undertook this study to determine if the cycle-length response of ventricular tachycardia (VT) to procainamide and amiodarone is similar in the individual patient. We enrolled 40 patients with uniform, monomorphic VT at a baseline, drug-free electrophysiologic study, after procainamide infusion and during oral amiodarone therapy. We found a significant correlation (p less than 0.01) between VT cycle-lengths on the 2 agents as well as the percent change in cycle length from baseline. Only 60% of the patients exhibited VT rates within 10% between the 2 agents. Importantly, less than 20% of patients had further slowing of the VT rate (greater than 10% slowing) during amiodarone therapy as compared to procainamide. Thus, although the cycle-length response of VT to procainamide correlates with the cycle-length response to amiodarone, 40% of patients have a disparate response (greater than 10% difference in cycle length) to the 2 agents; additional slowing of VT rates in response to amiodarone beyond that seen with procainamide is unlikely. These results have important implications regarding the institution of amiodarone therapy and the need for repeat electrophysiologic testing during amiodarone therapy.
Authors:
P T Vaitkus; A E Buxton; M E Josephson; F E Marchlinski
Related Documents :
1934937 - Blood volume distribution during head-up tilt induced central hypovolaemia in man.
23470297 - Effect of milk on team sport performance following exercise-induced muscle damage.
19541717 - A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis.
2318787 - Adaptation of the inert gas frc technique for use in heavy exercise.
15795817 - Cardiac mitochondrial respiratory function and oxidative stress: the role of exercise.
12665537 - Effects of creatine supplementation and exercise training on fitness in men 55-75 yr old.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of cardiology     Volume:  66     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1990 Sep 
Date Detail:
Created Date:  1990-10-15     Completed Date:  1990-10-15     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  710-4     Citation Subset:  AIM; IM    
Affiliation:
Clinical Electrophysiology Laboratory, Hospital of the University of Pennsylvania, Philadelphia 19104.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / therapeutic use*
Cardiac Pacing, Artificial
Coronary Disease / complications*
Electrophysiology
Female
Heart / drug effects,  physiopathology
Humans
Male
Middle Aged
Procainamide / therapeutic use*
Tachycardia / drug therapy*,  etiology
Grant Support
ID/Acronym/Agency:
HL28093/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
1951-25-3/Amiodarone; 51-06-9/Procainamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical and pathophysiologic correlates of ST-T-wave abnormalities in coronary artery disease.
Next Document:  Atrial endocardial mapping in the rare form of atrial flutter.